PI3K/AKT/mTOR pathway inhibitors in triple-negative breast cancer: a review on drug discovery and future challenges
Mohammad Ahmed KhanDepartment of Pharmacology, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, 110062, IndiaVineet JainDelhi Pharmaceutical Sciences and Research University (DPSRU), New Delhi, 110017, IndiaMd. RizwanullahDepartment of Pharmaceutics, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, 110062, IndiaJaved AhmadDepartment of Pharmaceutics, College of Pharmacy, Najran University, Saudi Arabia. Electronic address: [email protected]Keerti JainDelhi Pharmaceutical Sciences and Research University (DPSRU), New Delhi, 110017, India. Electronic address: [email protected]
2019en
ABI
Annotatsiya
Annotatsiya mavjud emas.
Identifikatorlar
Iqtiboslar va manbalar
2 ta iqtibos0 ta foydalanilgan manba